Friday 6 November 2026 Export TRAX’s income statement to Excel — free account

First Tracks Biotherapeutics, Inc.

TRAX Healthcare Biotechnology

EPS: +40.5%
Free cash flow: +55.9%

Quarter to September 2026, against a year earlier

47.78 2.35 +5.17%

Follow TRAX

Alert me

Market cap: $1.9B
P/E: 0.0×
Fwd P/E: —
Dividend yield: —
F-score: n/a
Altman Z: n/a
Beneish M: n/a
Dividend safety: n/a

Overview

Columns are period end dates · fundamentals updated 5 Nov 2026